Showing results (21-30 of 92) with videos related to

Sort By:
Pageof 10
PPAR Research|August 26, 2014
TRPV1 Activation Attenuates High-Salt Diet-Induced Cardiac Hypertrophy and Fibrosis through PPAR-δ UpregulationFeng Gao, Yi Liang, Xiang Wang, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine|February 5, 2010
Sex difference in cardiometabolic risk profile and adiponectin expression in subjects with visceral fat obesityHongbo He, Yinxing Ni, Jing Chen, et al.
Cardiovascular Diabetology|April 24, 2013
TRPV1-mediated UCP2 upregulation ameliorates hyperglycemia-induced endothelial dysfunctionJing Sun, Yunfei Pu, Peijian Wang, et al.
Diabetes|June 6, 2012
Transient receptor potential vanilloid 1 activation enhances gut glucagon-like peptide-1 secretion and improves glucose homeostasisPeijian Wang, Zhencheng Yan, Jian Zhong, et al.
Journal of Cardiovascular Pharmacology|February 21, 2012
Atorvastatin attenuates TNF-α-induced increase of glucose oxidation through PGC-1α upregulation in cardiomyocytesFeng Gao, Yinxing Ni, Zhidan Luo, et al.
Pflugers Archiv : European Journal of Physiology|January 20, 2011
TRPV1 activation prevents high-salt diet-induced nocturnal hypertension in miceXinzhong Hao, Jing Chen, Zhidan Luo, et al.
Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]|November 1, 2013
Inflammatory factor-specific sumoylation regulates NF-κB signalling in glomerular cells from diabetic ratsSijiao Chen, Tao Yang, Furong Liu, et al.
American Journal of Physiology. Endocrinology and Metabolism|December 16, 2024
Roux-en-Y gastric bypass alleviates kidney inflammation and improves kidney function in db/db mice by activating TLCA/TGR5 pathwayHongmei Lang, Jie Xiang, Xiaorong Chen, et al.
Journal of Hypertension|April 25, 2012
Metformin-based treatment for obesity-related hypertension: a randomized, double-blind, placebo-controlled trialHongbo He, Zhigang Zhao, Jing Chen, et al.
Journal of Cellular and Molecular Medicine|May 19, 2010
Angiotensin II receptor blocker telmisartan enhances running endurance of skeletal muscle through activation of the PPAR-δ/AMPK pathwayXiaoli Feng, Zhidan Luo, Liqun Ma, et al.
Pageof 10